Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19

Saved in:

Bibliographic Details
Published in	Gastroenterology (New York, N.Y. 1943) Vol. 159; no. 3; pp. 1170 - 1172.e1
Main Authors	Tan, Nian-Di, Qiu, Yun, Xing, Xiang-Bin, Ghosh, Subrata, Chen, Min-Hu, Mao, Ren
Format	Journal Article
Language	English
Published	United States Elsevier Inc 01.09.2020 by the AGA Institute
Subjects	ACEI/ARB Aged Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Betacoronavirus Brief Communication China Coronavirus Infections - complications Coronavirus Infections - diagnosis Coronavirus Infections - mortality COVID-19 Digestive System Female Gastrointestinal Diseases - epidemiology Humans Hypertension - drug therapy Length of Stay Liver Injury Male Middle Aged Pandemics Pneumonia, Viral - complications Pneumonia, Viral - diagnosis Pneumonia, Viral - mortality Retrospective Studies SARS-CoV-2 Survival Rate Symptom Assessment China COVID-19 ARB Liver Injury GI ACE Digestive System ACEI ACEI/ARB GI, gastrointestinal ACEI, angiotensin-converting enzyme inhibitors ACE, angiotensin-converting enzyme COVID-19, coronavirus disease 2019 ARB, angiotensin receptor blockers
Online Access	Get full text
ISSN	0016-5085 1528-0012 1528-0012
DOI	10.1053/j.gastro.2020.05.034

More Information
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Authors share co-first authorship.
ISSN:	0016-5085 1528-0012 1528-0012
DOI:	10.1053/j.gastro.2020.05.034